NCCN Guidelines for Patients® | Esophageal Cancer - page 44

NCCN Guidelines for Patients
: Esophageal Cancer
Version 1.2013
Part 5: Squamous cell carcinomas
Supportive care:
Treatment for symptoms
that are caused by cancer
or by cancer treatment
surgical margins:
normal-looking tissue
around the edge of a tumor
Read pages 28–38
for information on
cancer treatments.
The recommended chemotherapy regimens for chemoradiation before
surgery are:
Preferred regimens
• Paclitaxel and carboplatin
• Cisplatin and fluoropyrimidine (5-FU or capecitabine)
• Oxaliplatin and fluoropyrimidine (5-FU or capecitabine)
Other regimens
• Irinotecan and cisplatin
• Docetaxel and fluoropyrimidine (5-FU or capecitabine)
• Paclitaxel and fluoropyrimidine (5-FU or capecitabine)
How the tumor responds to treatment will be assessed by a CT scan with
contrast, PET/CT, or upper GI endoscopy. These tests are described
in Parts 2.1 and 3.1. If there are no signs of cancer, you may have an
esophagectomy, or instead of treatment, you could start follow-up testing.
If cancer is found in or near the esophagus, an esophagectomy is strongly
recommended. Otherwise, supportive care can be started. Supportive care
is also recommended if tests show a T4b tumor or M1 disease.
Next steps:
When you are finished with cancer treatment, read Part 5.3 for
follow-up testing. If you will receive supportive care, read Part 5.5 next.
= computed tomography
= gastrointestinal
= positron emission
1...,34,35,36,37,38,39,40,41,42,43 45,46,47,48,49,50,51,52,53,54,...100
Powered by FlippingBook